Key Highlights

  • Revenue was USD 11.91 million against an estimate of USD 12.16 million.
  • Net income was USD 765,252, compared with USD 749,387.
  • Gross profit was USD 6.38 million, compared with USD 6.23 million.
  • Cash and cash equivalents were USD 12.59 million at September 30, 2026.

Research Solutions (NASDAQ:RSSS) reported Revenue of USD 11.91 million for the first quarter of fiscal 2027, which ended September 30, 2026, compared with USD 12.31 million in the prior-year quarter, against an estimate of USD 12.16 million. Basic and diluted Net Income per common share was USD 0.02, unchanged from the prior-year quarter.

Net income was USD 765,252, compared with USD 749,387. Income from operations was USD 920,875, compared with USD 961,671.

Revenue and Gross Profit

Platforms revenue was USD 5.31 million, compared with USD 5.12 million, and transactions revenue was USD 6.60 million, compared with USD 7.19 million. Total cost of revenue was USD 5.53 million, compared with USD 6.09 million. Platforms Gross Profit was USD 4.62 million, compared with USD 4.51 million, and transactions gross profit was USD 1.76 million, compared with USD 1.71 million. Total gross profit was USD 6.38 million, compared with USD 6.23 million.

Operating Expenses and Net Income

Sales and Marketing expenses were USD 1.46 million, compared with USD 1.67 million, and technology and product development expenses were USD 1.67 million, compared with USD 1.41 million. General and administrative expenses were USD 2.23 million, compared with USD 1.68 million, and Depreciation and amortization was USD 310,863, compared with USD 316,066. Stock-based compensation was a recovery of USD 196,549 due to forfeitures, compared with an expense of USD 212,482. Total operating expenses were USD 5.46 million, compared with USD 5.26 million.

Other income was USD 93,608, and accreted interest expense was USD 149,212, compared with USD 317,966. Income before the provision for income taxes was USD 865,271, compared with USD 770,618, and the provision for income taxes was USD 100,019, compared with USD 21,231. Weighted average common shares outstanding were 32,644,399 on a basic basis and 32,916,413 on a diluted basis.

Balance Sheet and Share Count

Cash and cash equivalents were USD 12,586,878 at September 30, 2026, compared with USD 12,630,283 at June 30, 2026. The company stated that the decrease was primarily due to cash used in financing activities, partially offset by cash provided by operating activities.

Total Assets were USD 45.43 million, compared with USD 45.66 million, and total current liabilities were USD 23.43 million. Total liabilities were USD 23.44 million, compared with USD 24.96 million. The filing reports 34,145,005 shares of common stock outstanding as of November 6, 2026.

Comprehensive income was USD 761,513, compared with USD 750,354, after a foreign currency translation adjustment of negative USD 3,739. Weighted average stock Options excluded from the diluted share count due to anti-dilution were 1,533,037, compared with 733,934 in the prior-year quarter. The dilutive effect of stock options was 272,014 shares, compared with 824,687.

Research Solutions Fiscal Q1 2027 Earnings: Key Takeaways

Research Solutions reported fiscal first quarter 2027 revenue of USD 11.91 million, gross profit of USD 6.38 million and net income of USD 765,252. Cash and cash equivalents were USD 12.59 million at September 30, 2026.